摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9a-benzylhexahydropyrrolo[1,2-a]azepin-5,9-dione | 913638-29-6

中文名称
——
中文别名
——
英文名称
9a-benzylhexahydropyrrolo[1,2-a]azepin-5,9-dione
英文别名
9a-benzylhexahydro-5H-pyrrolo[1,2-a]azepine-5,9(6H)-dione;9a-Benzyl-1,2,3,6,7,8-hexahydropyrrolo[1,2-a]azepine-5,9-dione
9a-benzylhexahydropyrrolo[1,2-a]azepin-5,9-dione化学式
CAS
913638-29-6
化学式
C16H19NO2
mdl
——
分子量
257.332
InChiKey
UKSXPVNGXYRTHP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    37.4
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    9a-benzylhexahydropyrrolo[1,2-a]azepin-5,9-dione 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 反应 0.75h, 以55%的产率得到(9S,9aR)-9a-benzyl-9-hydroxy-2,3,6,7,8,9-hexahydro-1H-pyrrolo[1,2-a]azepin-5-one
    参考文献:
    名称:
    Concise access to indolizidine and pyrroloazepine skeleta via intramolecular Schmidt reactions of azido 1,3-diketones
    摘要:
    容易制备的 2-烷基-2-叠氮丙基环烷基-1,3-二酮与一系列硬路易斯酸发生分子内施密特重排反应,生成吲哚二酮和吡咯氮杂环二酮。手性铝基路易斯酸也可用于介导这种打破对称性的转化,但没有观察到明显的不对称诱导。
    DOI:
    10.1039/b608801e
  • 作为产物:
    参考文献:
    名称:
    铜-氮烯催化的 1,3-二酮向双环内酰胺的不对称 Oxaziridination/1,2-烷基重排
    摘要:
    尽管铜-氮烯作为多种转化中的通用活性物质已被广泛研究,但涉及铜-氮烯的不对称反应仅限于烯烃的氮丙啶化反应。在此,我们报告了新型铜-氮烯催化的环状二酮与烷基叠氮化物的去对称 oxaziridination 反应以及所得高活性中间体的后续重排,该反应产生了具有合成挑战性的含有季碳中心的手性双环内酰胺。该过程不仅丰富了铜-氮烯催化的不对称反应,而且还提供了一种替代策略来解决催化不对称施密特反应的固有挑战。
    DOI:
    10.1002/anie.202107909
点击查看最新优质反应信息

文献信息

  • Chiral Brønsted Acid-Promoted Enantioselective Desymmetrization in an Intramolecular Schmidt Reaction of Symmetric Azido 1,3-Hexanediones: Asymmetric Synthesis of Azaquaternary Pyrroloazepine Skeletons
    作者:Ming Yang、Yu-Ming Zhao、Shu-Yu Zhang、Yong-Qiang Tu、Fu-Min Zhang
    DOI:10.1002/asia.201100171
    日期:2011.6.6
    The enantioselective desymmetrization of 2‐substituted‐2‐azidopropyl 1,3‐hexanediones through an asymmetric intramolecular Schmidt reaction using a chiral Brønsted acid has been developed for the first time. Synthetically interesting pyrroloazepine skeletons with an azaquaternary stereogenic center with up to 59 % ee are accessed effectively (see scheme; R=H, alkyl, or aryl).
    首次开发了使用手性布朗斯台德酸通过不对称分子内Schmidt反应对2-取代2-叠氮丙基1,3-己二酮进行对映选择性脱对称。合成有趣的吡咯并ze庚因骨架,其氮杂季铵立体异构中心的ee高达59%(请参阅方案; R = H,烷基或芳基)。
  • Copper‐Nitrene‐Catalyzed Desymmetric Oxaziridination/1,2‐Alkyl Rearrangement of 1,3‐Diketones toward Bicyclic Lactams
    作者:Xue Han、Li‐Xin Shan、Jin‐Xin Zhu、Chang‐Sheng Zhang、Xiao‐Ming Zhang、Fu‐Min Zhang、Hong Wang、Yong‐Qiang Tu、Ming Yang、Wen‐Shuo Zhang
    DOI:10.1002/anie.202107909
    日期:2021.10.11
    oxaziridination reaction of cyclic diketones with alkyl azides and the subsequent rearrangement of the resulting highly active intermediate, which produces a synthetically challenging chiral bicyclic lactam containing a quaternary carbon center. This procedure not only enriches the copper-nitrene-catalyzed asymmetric reactions, but also provides an alternative strategy to address the inherent challenges of catalytic
    尽管铜-氮烯作为多种转化中的通用活性物质已被广泛研究,但涉及铜-氮烯的不对称反应仅限于烯烃的氮丙啶化反应。在此,我们报告了新型铜-氮烯催化的环状二酮与烷基叠氮化物的去对称 oxaziridination 反应以及所得高活性中间体的后续重排,该反应产生了具有合成挑战性的含有季碳中心的手性双环内酰胺。该过程不仅丰富了铜-氮烯催化的不对称反应,而且还提供了一种替代策略来解决催化不对称施密特反应的固有挑战。
  • Concise access to indolizidine and pyrroloazepine skeleta via intramolecular Schmidt reactions of azido 1,3-diketones
    作者:Duanpen Lertpibulpanya、Stephen P. Marsden
    DOI:10.1039/b608801e
    日期:——
    Readily prepared 2-alkyl-2-azidopropylcycloalkyl-1,3-diones undergo intramolecular Schmidt rearrangement with a range of hard Lewis acids, leading to indolizidinediones and pyrroloazepinediones. Chiral aluminium-based Lewis acids could also be used to mediate this symmetry-breaking transformation, but no significant asymmetric induction was observed.
    容易制备的 2-烷基-2-叠氮丙基环烷基-1,3-二酮与一系列硬路易斯酸发生分子内施密特重排反应,生成吲哚二酮和吡咯氮杂环二酮。手性铝基路易斯酸也可用于介导这种打破对称性的转化,但没有观察到明显的不对称诱导。
查看更多

同类化合物

环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 吡咯并[1,2-a]氮杂-5-酮 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 (1R*,2E,11S*)-2-(cyclohexylmethylene)-1-(phenylsilyl)methyloctahydropyrrolo[1,2-a]azepine (R)-2-(6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]azepin-9-yl)-acetaldehyde curvulamine (3aR,8aS)-tert-butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride tert-butyl 6-(2-amino-2-oxoethyl)-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate 3-benzoyl-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-(tert-butyloxycarbonyl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethylazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethyl-6-methylazepino[4,5-b]indole (Z)-2,3,9,9a-tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-one 2,3,4,5,6,7-hexahydro-1H-3a,8,13,13b-tetraazabenzo[b]cyclopenta[1,2,3-jk]fluorene 2,3,4,5,6,7-hexahydro-1H-3a,8,11,11b-tetraazacyclohepta[1,2,3-jk]fluorene 1-Benzyloxy-2-methoxy-7,8,9,10-tetrahydro-6H-azepino<1,2-a>indole-11-carbaldehyde 3-benzoyl-10-(2-propoxyphenyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 2-phenyl-2,4,5,6-tetrahydro-1H-6-azabenzo[a]cyclohepta[cd]azulen-1-one 2-carbetoxy-3-(N,N-dimethyl)aminomethyleneamino-8-oxo-8H-4,5,6,7-tetrahydropyrrolo<2,3-c>azepine 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 5-(2-hydroxy-3-morpholin-4-yl-propyl)-3-methyl-4-oxo-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 11-(tert-butyldimethylsilyloxy)-1-trimethylsilyl-3a,4,11,12-tetrahydro-3H-cyclopenta[5,6]azepine[1,2-a]indole-2-one tert-butyl 8,9-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl 9,10-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl (1R,4S)-1-(benzylcarbamoyl)-3-oxo-2-((S)-1-phenylethyl)-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-4-ylcarbamate